Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 427 across all filing types
Latest filing 2023-06-13 Regulatory Filings
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of a share certificate and the consequent stop transfer of shares until a duplicate certificate is issued. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details about the lost certificate and shareholder. The document is short (2279 characters) and serves as an official notification rather than a financial report or detailed filing. It does not contain financial data, management discussion, or report publication information. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-13 English
Updates
Major Shareholding Notification Classification · 100% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the completion of sale of securities by a shareholder, Mr. Zakir Vali. It references compliance with SEBI regulations related to disclosure of material events and substantial acquisition of shares. The content is about notifying the exchange of a shareholder's transaction, not a financial report, earnings release, or management discussion. The document length is short (2517 characters) and it is an announcement of a material event related to shareholding. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2023-06-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the schedule of an Investors / Analysts Meet. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The document does not contain any financial data, detailed report content, or results. It is essentially an announcement of a meeting schedule and does not qualify as a financial report, earnings release, or any detailed investor presentation. The document length is only 2126 characters, which is short and typical for a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-12 English
Updates
Major Shareholding Notification Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding a potential sale of securities by a shareholder, Mr. Zakir Vali. It references compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to material event disclosures. The content focuses on informing the exchanges about a shareholder's intention to sell shares and the related escrow arrangements. There is no financial data, report, or detailed analysis present. The document is a regulatory announcement about a material event, specifically a shareholder's potential sale of shares, which fits the category of a Major Shareholding Notification (MRQ). The document length is short (3018 characters), and it is not an announcement of a report publication or certification. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2023-06-12 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation regarding the loss of share certificates and the consequent stop transfer of those shares. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which deals with share certificate loss and duplicate issuance. The document is addressed to stock exchanges' compliance departments and signed by the Company Secretary and Compliance Officer. It does not contain financial data, earnings, management discussion, or any report content. It is a regulatory announcement about share certificate status and stop transfer action, which fits best under Regulatory Filings (RNS) as it is a compliance notification without financial statements or report content.
2023-06-08 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a detailed press release and disclosure about credit rating assigned by CARE Ratings Limited to Zim Laboratories Limited. It includes extensive financial and operational information about the company, such as scale of operations, profitability, leverage, geographical presence, risks, and outlook. The document is not a full annual report but rather a credit rating update and rationale, which is a form of financial and credit information disclosure. It is not an earnings release, call transcript, or management report. It is also not a regulatory filing or announcement of a report publication. The content fits best under the category of Capital/Financing Update (CAP) because it provides an update on the company's credit rating and financial risk profile, which relates to financing and capital structure.
2023-06-06 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.